Black-swan watch: emergent clusters, actions losing effect, co-occurrence patterns across layers, adverse signals in responders, tracker anomalies across the program. A human sets the state.

What is emerging that nobody predicted?

Synthetic demo data

watchclusterEC-03 · High response / high intolerance

Early response followed by GI deterioration and treatment discontinuation.

first seen day 24n 18437 days before clinical recognition

P-01307 P-01311 P-01318 P-01323 P-01325 P-01327 P-01328 P-01330 P-01332 P-01336 P-01337 P-01339 P-01341 P-01349 P-01356 P-01359+168

watchtracker anomalySleep quality falling across the program where GI is rising

102 patients (17%) with worsening sleep and GI ≥ 40 in the same 14 days; sleep-window content is the cheapest lever.

first seen last 14 daysn 102

P-01307 P-01310 P-01311 P-01318 P-01321 P-01323 P-01327 P-01337 P-01339 P-01341 P-01360 P-01362 P-01364 P-01365 P-01368 P-01371+86

watchclusterEC-02 · Resilient responder

Strong response that survives an early toxicity episode.

first seen day 17n 3231 days before clinical recognition

P-01304 P-01308 P-01316 P-01351 P-01384 P-01411 P-01419 P-01453 P-01460 P-01471 P-01475 P-01479 P-01500 P-01503 P-01506 P-01525+16

watchclusterEC-01 · Delayed loss of response

Response builds, then fades from the second month without a toxicity signal.

first seen day 46n 3040 days before clinical recognition

P-01313 P-01345 P-01348 P-01350 P-01370 P-01377 P-01397 P-01401 P-01415 P-01450 P-01468 P-01483 P-01541 P-01601 P-01628 P-01650+14

watchco occurrenceGI burden + low mood + falling HRV in the same patients

A gut–mood–autonomic pattern that no single side-effect view shows. 20% carry the IL6 variant, 60% low butyrate.

first seen this windown 5-67% vs 30 d ago

P-01307 P-01454 P-01501 P-01808 P-01833